GlassScriptPhysician profile
Jeffrey Moody
NPI 1629013628
$8,044.96
in general payments reported to CMS, 2019-2025
47 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,332 · 2020: $549 · 2021: $410 · 2022: $382 · 2023: $1,037 · 2024: $1,059 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,372.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,682.10 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue |
| Medtronic USA, INC. | $532.13 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $445.32 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $420.64 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic, INC. | $364.91 | 2021-2024 | Interstim |
| Covidien LP | $335.00 | 2019 | |
| Janssen Biotech, INC. | $330.25 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $276.52 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $263.26 | 2020-2023 | Provenge |
| Abbvie INC. | $245.93 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $177.37 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $171.47 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Procept Biorobotics Corporation | $168.01 | 2025 | |
| Progenics Pharmaceuticals, INC. | $150.41 | 2022-2025 | Pylarify |
| Dornier Medtech America, INC | $112.70 | 2025 | Dornier Medtech |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.